Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.
about
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor modelsFocus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human gliomaDendritic cell vaccines for brain tumorsFunctional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homingImmune Evasion Strategies of GlioblastomaImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentAntibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsDendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trialsImmunotherapy for brain cancer: recent progress and future promiseImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Are BiTEs the "missing link" in cancer therapy?Multiple Sclerosis and T Lymphocytes: An Entangled StoryTherapeutic cancer vaccines and combination immunotherapies involving vaccinationT cells enhance stem-like properties and conditional malignancy in gliomasPeripheral tissue homing receptor control of naïve, effector, and memory CD8 T cell localization in lymphoid and non-lymphoid tissues.Human cerebrospinal fluid contains CD4+ memory T cells expressing gut- or skin-specific trafficking determinants: relevance for immunotherapy.Autoimmune T cell responses in the central nervous systemMucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumorsHuman IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model.Overview of cellular immunotherapy for patients with glioblastoma.Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human gliomaSynergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumoursImmunotherapy of rat glioma without accumulation of CD4(+)CD25(+)FOXP3(+) regulatory T cellsOral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challengeTargeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infectionEfficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route.Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brainImmunotherapy for human glioma: innovative approaches and recent results.Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy.MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8⁺ T cells.Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection.Dissecting T cell lineage relationships by cellular barcoding.Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids.Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain
P2860
Q21245475-9D96C932-1B54-44EA-801D-B96034F12CE2Q24615166-B4EB8706-714E-428C-B571-D7166307878EQ24641823-F897CCA3-CF75-46E3-BA1F-2001B3D377B8Q24646057-FDA484B7-8DFC-483E-A986-50E6A907B83EQ26765855-35038D4F-88AB-4D01-8771-CE498A4A7F15Q26798402-2594E268-DE8B-4680-87C6-089552BE101FQ26799117-A0C793DA-FF38-4663-BD6C-8D14FD067FE0Q27011298-98F47286-475A-4336-AFD0-B9F866F5C32BQ27014829-3D082BF8-717D-4EAC-A462-51C195FF72DBQ27015881-A98512A4-32A2-4E48-808E-0E5B2B1E26F1Q28078539-A6153D63-EE64-4D06-90A5-1C1FDD6A93DBQ28083907-EA4E1F1E-476E-450D-BD1F-84A28879B98FQ28086853-903AD40B-8674-4EF1-8B20-9BDF1759613CQ28397609-72240EF4-BB4D-43E9-B056-116DEDAF3EC2Q28474262-7F3AA4EF-0AD2-4B9E-8F43-F3BD686A60C7Q30417609-345476CB-BBCE-45D5-90C8-F4A055B119EBQ33249100-3B0CB801-1678-43FF-BDD6-68A01BB037F0Q33620003-F08C640E-AE80-4CDD-8F77-C9EE5DCF9317Q33862822-96FBC21C-A99F-49E7-BE47-B2EE749C326EQ34152633-99C3E673-E67F-43B2-92BC-BC30AA381BC7Q34189694-26C5F854-D12E-449A-BAC5-0BD4B3DD5A3BQ34457611-667B467E-EC51-4AF5-AB37-2CA53183BBD2Q34480557-91A61A24-155F-451B-BB56-FD393EA406EFQ34657329-89FFC937-09CD-43A9-A13D-D97343B40D33Q34744875-3F587D67-AC78-4568-9A45-2F3B1BA3988AQ35020804-1BD352AA-F848-4858-9B09-CDEED4BDA784Q35139381-F1E3A154-1B4E-4495-9142-D843A139FCD3Q35193006-81D2FF27-64DF-442D-B10B-D708BC3A73B8Q35224721-C999C1FE-8A19-4EB7-A25E-98A49C4EC061Q35728235-F66D4665-EDB6-4D2F-9C00-FED0E57C6A09Q35799695-633F0146-6FEE-4F2A-92B2-9B8D5A025EB8Q36019340-8F7E1B95-64A3-4D99-B779-B17CB9A225D6Q36284489-FA59FD06-747F-4FB8-9904-8E8A2ED9E779Q36498016-DC316D31-EB5F-4178-AAA3-A271724B5A8DQ36568984-A0D92FE6-9040-457D-B12C-0154019E56B3Q36636588-28E0DCAC-9740-4021-86BD-EEDB5B73F1E8Q36747697-855A93B4-C4BA-4C67-B811-45006473713DQ36916393-19A82183-819E-46AC-ABA4-52E80B1A4E9AQ36965944-8BEEC163-19E5-4FF2-B976-1BA60E25EC60Q37037932-851E8C2C-D082-4FBC-8B03-66D08FC87AD2
P2860
Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Homing phenotypes of tumor-spe ...... site by crosspresenting APCs.
@en
type
label
Homing phenotypes of tumor-spe ...... site by crosspresenting APCs.
@en
prefLabel
Homing phenotypes of tumor-spe ...... site by crosspresenting APCs.
@en
P2093
P50
P1433
P1476
Homing phenotypes of tumor-spe ...... r site by crosspresenting APCs
@en
P2093
Curzio Rüegg
Emmanuel Contassot
Pierre-Yves Dietrich
Rick Wilmotte
Wilma Di Berardino-Besson
P304
P356
10.1016/J.IMMUNI.2004.12.008
P407
P577
2005-02-01T00:00:00Z